Reply to: RE>Kim Campbell comments
From the response of Rick and Kim to my comments about markers, my remarks may
have been misconstrued. I was not suggesting that we only map the Sumai 3/Ning 7840 resistance. However, that seems to be what almost everybody is working with, and the only resistance that has been genetically characterized so far. As other sources of resitance are discovered AND characterized genetically and phenotypically, they should also be mapped. I agree with Rick that there seem to be several other sources of resistance, both "exotic" amd within adapted cultivars, but until these are carefully characterized, I think it is premature to look for markers. The main point of my comments was is it necessary for every state to do the screening for markers for the same source of resistance? My idea was that one or two labs should concentrate on Rick's objective no. 1 for a given source of resistance. Once putative markers are found, these should be made available to all states to pursue objectives 2 and 3. Since I don't do marker work myself, I don't know what the relative costs of objectives 1, 2, and 3 are, but I have the impression that No. 1 (finding the markers) can be very expensive because it is such a "needle in the haystack" proposition. Maybe some of the newer marker technologies are more efficient. Anyway, my original question still stands. Will it look bad to send in a proposal that shows the marker budget being equally divided among all states? Will the proposal be stronger if it shows an overall budget for marker work, and specifies that this money will be used for the three objectives Rick mentions, and that money will will allocated to states according to the degree of their participation in these three objectives? If it turns out that there are enough different sources of resistance that are genetically charactized for every state to share in all three objectives, and therefore each state gets about the same amount of marker money, then that's fine. With regard to Kim's second point about the allocation of money over the general objectives, I don't see plant pathology and plant breeding as entirely separate activities with respect to scab. Plant breeders and plant pathologists will need to work closely together to develop reliable screening techniques and evaluate germplasm. I am not sure that breeding will be a quicker fix than fungicides. If effective fungicides are found, there are mechansisms for getting special use permits and these could be in place probably sooner than resistant cultivars would be generally available. This partly depends on whether an effective fungicide is already registered for use in the US. The epidemiology work is important, but by itself will not provide a radical solution to the scab problem. We already have a good idea about the reasons why scab has become a much greater problem in recent years. Additional studies on epidemiology will fill in some gaps in our knowledge and refine our understanding of the conditions favorable for disease. These studies will certainly help create reliable resistance or fungicide screening tests. So, I think the overall allocation of money among the various control strategies is logical and should provide the greatest chance for putting scab control solutions in farmers' hands in the shortest possible time.
Regards, Greg